Literature DB >> 19594090

Hydroxyethyl starch 130/0.4 versus modified fluid gelatin for cardiopulmonary bypass priming: the effects on postoperative bleeding and volume expansion needs after elective CABG.

J Vanhoonacker1, M Ongenae, H Vanoverschelde, R Donadoni.   

Abstract

UNLABELLED: Concerned about high dose starches and potential coagulopathy, we performed a double blinded randomised prospective study on the influence of gelatine or 6% HES 130/04 pump prime on postoperative blood loss and transfusion requirements after CABG surgery.
METHODS: After informed consent, 157 electively scheduled patients were randomly allocated to 6% HES (n=85) or gelatine (n=72) CPB priming. Postoperatively, chest tube drainage was noted hourly during the first 24 hours and every unit of colloid, albumin, FFP or Packed Red Cells needed to maintain hemodynamic stability was carefully registered. Blood losses were standardised as ml blood loss/kg body weight. Three patients in the HES group were excluded from the study because of postoperative haemorrhage of pure surgical origin. Data analysis consisted in unpaired t-test and Fisher exact test where appropriate.
RESULTS: Chest tube drainage was significantly higher at 1 hour in the HES group (2.38 ml/kg vs. 3.15 ml/kg, p = 0.03). At 24 hours, total blood loss was still higher in the HES group without reaching statistical significance (p = 0.07). Albumin supplements occurred more frequently in the HES group between 2 and 3 hours postoperatively (p = 0.02). Total artificial colloid supplement was significantly higher in the gelatin group (13.36 versus 8.96 ml/kg, p < 0.001). There were no differences in the number of packed red cells, fresh frozen plasma or platelets transfused between the two groups.
CONCLUSION: 6% HES 130/0.4 is a safe alternative to gelatine pump prime with a volume effect persisting longer in the postoperative phase, mandating less volume expansion with artificial colloid during the first 24 postoperative hours and not causing additional allogeneic blood component exposure.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19594090

Source DB:  PubMed          Journal:  Acta Anaesthesiol Belg        ISSN: 0001-5164


  7 in total

Review 1.  Hydroxyethyl starch for cardiovascular surgery: a systematic review of randomized controlled trials.

Authors:  Xue-Yin Shi; Zui Zou; Xing-Ying He; Hai-Tao Xu; Hong-Bin Yuan; Hu Liu
Journal:  Eur J Clin Pharmacol       Date:  2011-03-02       Impact factor: 2.953

Review 2.  Colloid solutions for fluid resuscitation.

Authors:  Frances Bunn; Daksha Trivedi
Journal:  Cochrane Database Syst Rev       Date:  2012-07-11

3.  Update on transfusion solutions during surgery: review of hydroxyethyl starches 130/0.4.

Authors:  Ornella Piazza; Giuliana Scarpati; Rosalba Tufano
Journal:  Int J Gen Med       Date:  2010-10-05

4.  The use of meta-analyses for benefit/risk re-evaluations of hydroxyethyl starch.

Authors:  Christian J Wiedermann
Journal:  Crit Care       Date:  2015-06-02       Impact factor: 9.097

5.  The impact of hydroxyethyl starches in cardiac surgery: a meta-analysis.

Authors:  Matthias Jacob; Jean-Luc Fellahi; Daniel Chappell; Andrea Kurz
Journal:  Crit Care       Date:  2014-12-04       Impact factor: 9.097

6.  Effects of crystalloid and colloid priming strategies for cardiopulmonary bypass on colloid oncotic pressure and haemostasis: a meta-analysis.

Authors:  Anne Maria Beukers; Jamy Adriana Catharina de Ruijter; Stephan Alexander Loer; Alexander Vonk; Carolien Suzanna Enna Bulte
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-08-03

7.  Comparing the Effects of 5% Albumin and 6% Hydroxyethyl Starch 130/0.4 (Voluven) on Renal Function as Priming Solutions for Cardiopulmonary Bypass: A Randomized Double Blind Clinical Trial.

Authors:  Mahmood Hosseinzadeh Maleki; Pooya Derakhshan; Amir Rahmanian Sharifabad; Ahmad Amouzeshi
Journal:  Anesth Pain Med       Date:  2016-01-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.